Deutsche Bank AG increased its holdings in shares of Select Medical Holdings Co. (NYSE:SEM - Free Report) by 47.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 93,316 shares of the health services provider's stock after buying an additional 30,023 shares during the quarter. Deutsche Bank AG owned about 0.07% of Select Medical worth $1,759,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds have also recently added to or reduced their stakes in the business. Smartleaf Asset Management LLC lifted its holdings in shares of Select Medical by 179.0% during the 4th quarter. Smartleaf Asset Management LLC now owns 2,296 shares of the health services provider's stock worth $43,000 after acquiring an additional 1,473 shares during the period. Covestor Ltd raised its stake in Select Medical by 33.5% during the fourth quarter. Covestor Ltd now owns 4,955 shares of the health services provider's stock worth $93,000 after purchasing an additional 1,244 shares during the period. Quarry LP boosted its holdings in shares of Select Medical by 963.0% in the 4th quarter. Quarry LP now owns 9,078 shares of the health services provider's stock valued at $171,000 after purchasing an additional 8,224 shares during the last quarter. HBK Investments L P acquired a new position in shares of Select Medical in the 4th quarter valued at $188,000. Finally, Cibc World Markets Corp acquired a new stake in shares of Select Medical during the 4th quarter worth $191,000. 89.48% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
SEM has been the subject of a number of research reports. Wall Street Zen raised Select Medical from a "hold" rating to a "buy" rating in a research report on Friday, February 21st. Mizuho initiated coverage on Select Medical in a report on Wednesday, April 16th. They set an "outperform" rating and a $25.00 target price for the company. Benchmark raised shares of Select Medical from a "hold" rating to a "buy" rating and set a $23.00 target price for the company in a research report on Monday, February 24th. Finally, Royal Bank of Canada reduced their price target on shares of Select Medical from $23.00 to $19.00 and set an "outperform" rating on the stock in a research report on Wednesday, May 7th. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $26.00.
View Our Latest Analysis on SEM
Insider Buying and Selling
In other news, CEO David S. Chernow sold 225,000 shares of the business's stock in a transaction that occurred on Monday, April 28th. The stock was sold at an average price of $18.00, for a total value of $4,050,000.00. Following the completion of the sale, the chief executive officer now directly owns 714,516 shares in the company, valued at approximately $12,861,288. The trade was a 23.95% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Parvinderjit S. Khanuja acquired 21,000 shares of the firm's stock in a transaction on Monday, May 5th. The stock was acquired at an average cost of $15.02 per share, with a total value of $315,420.00. Following the acquisition, the director now owns 65,089 shares of the company's stock, valued at $977,636.78. This trade represents a 47.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders own 11.60% of the company's stock.
Select Medical Stock Up 3.1%
Shares of SEM stock traded up $0.45 during trading hours on Thursday, reaching $15.11. The company had a trading volume of 1,803,886 shares, compared to its average volume of 924,272. The company has a market capitalization of $1.94 billion, a P/E ratio of 9.16, a price-to-earnings-growth ratio of 0.64 and a beta of 1.40. The company has a debt-to-equity ratio of 1.37, a quick ratio of 1.13 and a current ratio of 1.13. Select Medical Holdings Co. has a twelve month low of $14.03 and a twelve month high of $40.98. The stock's fifty day simple moving average is $15.98 and its 200 day simple moving average is $19.39.
Select Medical (NYSE:SEM - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The health services provider reported $0.44 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.45 by ($0.01). The firm had revenue of $1.35 billion for the quarter, compared to analysts' expectations of $1.40 billion. Select Medical had a net margin of 3.23% and a return on equity of 14.04%. The company's revenue for the quarter was down 24.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.75 EPS. As a group, sell-side analysts expect that Select Medical Holdings Co. will post 1.17 earnings per share for the current fiscal year.
Select Medical Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Thursday, May 29th. Stockholders of record on Thursday, May 15th will be given a dividend of $0.0625 per share. This represents a $0.25 dividend on an annualized basis and a dividend yield of 1.65%. The ex-dividend date of this dividend is Thursday, May 15th. Select Medical's payout ratio is 18.66%.
Select Medical announced that its Board of Directors has authorized a share repurchase program on Thursday, May 1st that authorizes the company to buyback $1.00 billion in outstanding shares. This buyback authorization authorizes the health services provider to purchase up to 42.6% of its stock through open market purchases. Stock buyback programs are often a sign that the company's management believes its shares are undervalued.
Select Medical Company Profile
(
Free Report)
Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.
Read More

Before you consider Select Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Select Medical wasn't on the list.
While Select Medical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.